Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma

スポンサーリンク

概要

• 論文の詳細を見る

• Intravascular large B-cell lymphoma (IVL) is rare aggressive disseminated lymphoma associated with poor outcomes. Rituximab is a novel molecular agent that can reportedly improve outcomes for patients with diffuse large B-cell lymphoma. However, the safety and efficacy of rituximab in patients with IVL are unclear. A 76-year-old woman was hospitalized due to altered consciousness, fever and respiratory abnormalities. Definitive diagnosis of IVL was obtained following repeated biopsies of bone marrow. The patient received chemotherapy consisting of cyclophosphamide, vincristine, doxorubicin, prednisolone, and rituximab (R-CHOP), and achieved complete remission after 3 courses of treatment. She has remained in complete remission for over 3 years after diagnosis. This report suggests that rituximab-containing regimens could be safe and effective for elderly patients with IVL. [J Clin Exp Hematopathol 48(1) : 25-28, 2008]

• 日本リンパ網内系学会の論文
• 2008-05-01

著者

• NAOE Tomoki

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• Suzuki Tatsuya

  Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University

• SHIMADA Kazuyuki

  Department of Medicine, Jichi Medical University

• Tobinai K

  Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital

• MORI Naoyoshi

  Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine

• KINOSHITA Tomohiro

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• Tsuboi Naoya

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• NARIMATSU Hiroto

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• Komatsu H

  Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie

• ITO Masafumi

  Department of Pathology, Japanese Red Cross Nagoya Daiichi Hospital

• Naoe Tomoki

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Tanimoto Kazuki

  国立がんセンター中央病院

• Naoe Tomoki

  名古屋大学 医学系研究科血液･腫瘍内科学

• KIYOI Hitoshi

  Nagoya University Hospital

• KOSUGI Hiroshi

  Department of Hematology, Ogaki Municipal Hospital

• SHIMADA Satoko

  Department of Pathology and Clinical Laboratories, Nagoya University Hospital

• Mori Naoyoshi

  Department Of Pathology Of Biological Response Nagoya University Graduate School Of Medicine

• Mori Naoyoshi

  Department Of Ophthalmology And Pathology Nagoya University School Of Medicine

• Kiyoi Hitoshi

  豊橋市民病院 血液･腫瘍内科

• Kosugi H

  Department Of Hematology Ogaki Municipal Hospital

• Naoe T

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Kosugi Hiroshi

  Department Of Hematology Ogaki Municipal Hospital

• Kuroishi Tetsuo

  愛知県がんセンター研究所

• Ito Masafumi

  Department Of Pathology Japanese Red Cross Nagoya First Hospital

• Shimada Kazuyuki

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Naoe Tomoki

  Department Of Hematologly And Oncology Nagoya University School Of Medicine

• Takatsuki K

  Kumamoto Univ. School Of Medicine Kumamoto Jpn

• Ito Masafumi

  Department Of Hematology Yamanashi Prefectural Central Hospital

• Narimatsu Hiroto

  豊橋市民病院 血液･腫瘍内科

• Narimatsu Hiroto

  Department Of Hematology And Oncology Ja Aichi Showa Hospital

• Kinoshita T

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Kinoshita Tomohiro

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Kosugi Hiroshi

  Institute For Chemical Research Tohoku University

• Tobinai Kensei

  National Cancer Center Hospital

• Suzuki Tatsuya

  Department Of Electronic-mechanical Engineering Graduate School Of Engineering Nagoya University

• Inoue Masakazu

  Department Of Pathology Japanese Red Cross Nagoya First Hospital

• Takeyama K

  National Cancer Center Hospital Tokyo Jpn

• Shimada Kazuyuki

  Department Of Anatomy School Of Medicine Showa University

• Ito Masafumi

  Department Of Electrical And Electronic Engineering Faculty Of Science And Technology Meijo Universi

• Naruse T

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Shimada Satoko

  Department Of Pathology And Biological Response Nagoya University Graduate School Of Medicine

• Suzuki Tatsuya

  Department Of Electrical And Electronic Engineering Faculty Of Engineering Tokyo Institute Of Techno

• Suzuki Tatsuya

  Department Of Hematology Ogaki Municipal Hospital

• Suzuki Tatsuya

  Department Of Chemistry And Biotechnology School Of Engineering The University Of Tokyo

• Nakano Tatsunori

  Second Departmant Of Medicine Nagoya City University Medical School

• ITO Masafumi

  Department of Pathology, Japanese Red Cross, Nagoya First Hospital

• KINOSHITA Tomohiro

  Department of Hematology and Cell Therapy, Aichi Cancer Center

関連論文

• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• PJ-587 Role of Relaxin in Ventricular Remodeling after Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-4 (IHD) PJ99,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation So
• A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study
• Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
• Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
• Isolated Tricuspid Valve Endocarditis Due to Candida Parapsilosis Associated with Long-term Central Venous Catheter Implantation
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• OE-286 Orthostatic Hypertension Detected by Home BP is a Risk Factor of Trace Albuminuria Even in Normoalbuminuric Patients with Morning Hypertension(OE49,Hypertension, Clinical 1 (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The J
• Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
• Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
• Mutational analysis of SOS1 gene in acute myeloid leukemia
• Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
• Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
• Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
• BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
• Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
• Downregulation of microRNAs-143 and -145 in B-cell malignancies
• let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
• A Case of Interstitial Pneumonia Induced by Rituximab Therapy
• Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
• Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
• Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
• Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
• Bilateral tubal pregnancies after the termination of intrauterine pregnancy following gamete intrafallopian transfer
• Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
• Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
• Hyperactivate(HA)運動パターンによるヒト精子受精能の予測
• Scheduling for a Large-Scale Production System Based on a Continuous and Timed Petri-Net Model
• Acquisition and Modeling of Driving Skills by Using Three Dimensional Driving Simulator(Intelligent Transport System)
• Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
• Successful management of pregnancy in a patient with Segawa disease : Case report and literature review
• Fabrication and Optical Characterization of Five-Layer Asymmetric Coupled Quantum Well (FACQW)
• Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
• Nucleophosmin : A versatile molecule associated with hematological malignancies
• Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
• Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
• Antitumor effect of arsenic trioxide in murine xenograft model
• Isolation of NPC1-Deficient Chinese Hamster Ovary Cell Mutants by Gene Trap Mutagenesis^1
• Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
• Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
• Quality of Life in Adult Patients after Bone Marrow Transplantation
• IS1-04 Oxidative stress subsides by time after living related liver transplantation in pediatric age(Liver and Biliary ductal system,Share Smiles with Sick Children, Dreams and Innovation for Pediatric Surgery)
• Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
• Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• "Tension-free" Herniorrhaphy for Groin Hernias in Patients with Cirrhosis : Report of Four Cases
• Major complications and outcome of diagnostic and operative transvaginal hydrolaparoscopy
• Establishment of criteria for elective single embryo transfer at day 2 or day 3 by analyzing cases with successful implantation of all embryos transferred
• Effects of in vivo exposure to eggs with sperm-immobilizing antibodies in follicular fluid on subsequent fertilization and embryo development in vitro
• Severe ovarian hyperstimulation syndrome in a 42-year-old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer
• Successful pregnancy following conservative treatment of massive ascites associated with acute Chlamydia trachomatis peritonitis
• Randomized study comparing day 2 versus day 3 elective transfer of two good-quality embryos
• Accuracy of sperm velocity assessment using the Sperm Quality Analyzer V
• Application of transvaginal hydrolaparoscopy for ovarian drilling using Nd : YAG laser in infertile women with polycystic ovary syndrome
• Establishment and application of criteria for the elective transfer of two good-quality embryos to reduce high-order multiple pregnancies
• Influence of endometrial thickness and pattern on pregnancy rates in in vitro fertilization-embryo transfer
• Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
• Acute myeloid leukemia in the elderly : 159 Nagoya case studies
• Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
• Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
• Immunoglobulin Variable Region Structure and B-Cell Malignancies
• Dimensional Explanation of Capacity and Ambiguity in Information Theory
• Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
• Entropy and Safety Monitoring Systems
• A Procera^【○!R】 Custom Abutment Fabricated by Scanning the Provisional Abutment
• Multi-Hierarchical Modeling of Driving Behavior Using Dynamics-Based Mode Segmentation
• Identification of Positioning Skill Based on Feedforward/Feedback Switched Dynamical Model
• Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
• Profiling of proteins phosphorylated or dephosphorylated during hyperactivation via activation on hamster spermatozoa
• Electrooptic Characterization of Five-Layer Asymmetric Coupled Quantum Well
• Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
• Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
• Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
• Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
• Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
• Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
• Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
• Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
• Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
• Mutation of ARHGAP9 in patients with coronary spastic angina
• Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
• Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
• Guest editorial : Introducing progress in hematology in this issue

もっと見る 閉じる

スポンサーリンク